TCI Peptide Therapeutics Overview
- Founded
- 2009
- Status
- Private
- Employees
- 4
- Latest Deal Type
- Grant
- Latest Deal Amount
- $5.02M
- Investors
- 5
TCI Peptide Therapeutics General Information
Description
Developer of therapeutics intended to help create drugs for the treatment of cachexia. The company's drugs are melanocortin based peptide drugs for treating cardiovascular problems which are free from any adverse cardiovascular side effects, enabling healthcare practitioners to use these drugs for proper treatment of cancer and other chronic diseases.
Contact Information
Website
Formerly Known As
Tensive Controls
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- 1601 South Providence Road
- Columbia, MO 65211
- United States
+1 (573) 000-0000
TCI Peptide Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Grant | 01-Jun-2017 | $5.02M | 00.000 | Completed | Generating Revenue | |
| 4. Later Stage VC (Series A) | 01-Jun-2016 | 00.000 | 00.000 | Completed | Generating Revenue | |
| 3. Grant | 01-Jan-2014 | 0000 | Completed | Generating Revenue | ||
| 2. Grant | 01-Jan-2012 | $1.75M | Completed | Startup | ||
| 1. Early Stage VC | Completed | Startup |
TCI Peptide Therapeutics Executive Team (4)
TCI Peptide Therapeutics Board Members (1)
| Name | Representing | Role | Since |
|---|---|---|---|
| Jake Halliday Ph.D | TCI Peptide Therapeutics | Chief Executive Officer & Chairman | 000 0000 |
TCI Peptide Therapeutics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialTCI Peptide Therapeutics Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Centennial Investors | Angel Group | Minority | 000 0000 | 000000 0 | |
| United States Department of Agriculture | Government | 000 0000 | 000000 0 | ||
| National Cancer Institute | Government | 000 0000 | 000000 0 | ||
| U.S. Department of Health and Human Services | Government | 000 0000 | 000000 0 | ||
| Missouri Technology Corporation | Venture Capital | Minority | 000 0000 | 000000 0 |